PharmacoEconomics & Outcomes News

, Volume 818, Issue 1, pp 12–12 | Cite as

Clopidogrel vs aspirin in acute coronary syndrome in China

Clinical study


  1. Zhang L, et al. Clopidogrel Versus Aspirin for the Treatment of Acute Coronary Syndrome After a 12-Month Dual Antiplatelet Therapy: A Cost-effectiveness Analysis From China Payer's Perspective. Clinical Therapeutics : 20 Nov 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations